Powered by
-BAUSCH + LOMB RECEIVES 510 CLEARANCE FOR CRYSTALSERT 2.6 INJECTOR FOR CRYSTALENSAO and TRULIGN TORIC IOLs

BRIDGEWATER - Bausch + Lomb, a leading global eye health company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Crystalsert 2.6 injector (CI-26).

Designed exclusively for use across the entire diopter range of Crystalens AO and Trulign toric intraocular lenses (IOLs), the CI-26 facilitates smooth and easy delivery through an incision as small as 2.6 mm1.

'The CI-26 Injector includes several enhancements designed t

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox